The Medical University of South Carolina (MUSC) Foundation for Research and Development has developed a new diagnostic tool for the detection and monitoring of bladder cancer. The current tests for bladder cancer have an accuracy rate of only 40%, whereas the new test has established 90% accuracy (100% specificity). The new tool that tests human urine samples confirms the efficacy of a newly discovered cell receptor in diagnosing bladder cancer.